Corbus Pharmaceuticals Holdings, Inc. (CRBP) — research page
US · us-cm-kg/NASDAQ/CRBP · as of 2026-11-08
Identity and listing
The issuer is Corbus Pharmaceuticals Holdings, Inc., listed on NASDAQ under ticker CRBP, with ISIN US21833P3010 and LEI 529900MX6XCNZC7MM155. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States — Delaware. The segment is not on the record. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Corbus Pharmaceuticals Holdings, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | CRBP | source · 2026-11-08 |
| ISIN | US21833P3010 | source · 2026-10-08 |
| LEI | 529900MX6XCNZC7MM155 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 80 filings in the twelve months to 2026-11-08, across 48 filing days. The median gap between filing days is 5 days. The latest filing is 6 days before the record date, on 2026-11-02, and is of type directors_dealings. On NASDAQ the median filings in the window is 52, the median cadence gap is 6.0 days and the median latency is 5.0 days. On 2834 Pharmaceutical Preparations the median filings in the window is 63.0, the median cadence gap is 6.0 days and the median latency is 4.0 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 80 | 5 | 6 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-02 | directors_dealings | 4 | 4 |
| 2026-11-02 | regulatory_filing | SCHEDULE 13G/A | SCHEDULE 13G/A |
| 2026-10-29 | regulatory_filing | SCHEDULE 13G/A | SCHEDULE 13G/A |
| 2026-10-15 | corporate_news | 8-K | 8-K — 8-K (items 7.01,9.01) |
| 2026-09-30 | regulatory_filing | SCHEDULE 13G | SCHEDULE 13G |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.
Orderability
The orderability outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's own investor-relations page names 10 research houses: B Riley, Guggenheim, HC Wainwright, Jefferies, LifeSCI Capital, Mizuho Bank, Oppenheimer & Co Inc., RBC Capital Markets, Wedbush and William Blair.
| research house | analyst | source · read date |
|---|---|---|
| B Riley | Mayank Mamtani | issuer page · 2026-11-11 |
| Guggenheim | Paul Jeng | issuer page · 2026-11-11 |
| HC Wainwright | Andres Maldonado | issuer page · 2026-11-11 |
| Jefferies | Amin Makarem | issuer page · 2026-11-11 |
| LifeSCI Capital | Oliver McCammon | issuer page · 2026-11-11 |
| Mizuho Bank | Graig Suvannavejh | issuer page · 2026-11-11 |
| Oppenheimer & Co Inc. | Jeffrey Jones | issuer page · 2026-11-11 |
| RBC Capital Markets | Brian Abrahams | issuer page · 2026-11-11 |
| Wedbush | Robert Driscoll, Ph. D. | issuer page · 2026-11-11 |
| William Blair | Andy Hsieh, Ph.D. | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage is sealed. The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The earliest sealed date of the market is 2021-01-04, and the live record began on 2026-09-12.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001595097.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/CRBP (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://ir.corbuspharma.com/analyst-coverage (coverage)
- 10.9
- https://mcp.us-cm-kg.ai/record/NASDAQ/CRBP (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US21833P3010"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:884b75b5b14d45df.